PortViewPortView
Novavax logo

Novavax (NVAX) Stock Analysis

NASDAQHealthcareBiotechnology

$10.18+0.54%
1-year price historyRange $6.22 – $11.19
52-week range$10.18
$6.20$11.97

What Novavax does

Novavax, Inc. is a biotechnology firm dedicated to discovering, developing, and commercializing vaccines aimed at preventing serious infectious diseases and addressing critical health needs. The company's diverse pipeline includes NVX-CoV2373, a coronavirus vaccine candidate currently undergoing two Phase III trials, one Phase IIb, and one Phase I/II trial. Also featured is NanoFlu, a nanoparticle-based seasonal quadrivalent influenza vaccine in Phase 3 clinical trials. Furthermore, Novavax is advancing ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine, which is in Phase II clinical trials for adults aged 60 and older, and in Phase I for pediatric use. The company holds a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of its COVID-19 vaccine candidate, NVX-CoV2373. Established in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland.

Key metrics

Market cap
$1.67B
P/E (TTM)
-6.69
EPS (TTM)
$-1.52
Beta
2.42
Dividend yield
0.00%
Revenue / share
$2.51
50-day avg
$8.49
200-day avg
$8.50
52-week high
$11.97
52-week low
$6.20
CEO
John Charles Jacobs

ETFs linked to NVAX

Broad-market and Healthcare sector ETFs an investor holding Novavax is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how NVAX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze NVAX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Novavax?
Novavax trades under the ticker NVAX on NASDAQ.
Which exchange is NVAX listed on?
NVAX is listed on NASDAQ.
What sector does Novavax operate in?
Novavax is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze NVAX in a portfolio?
PortView shows NVAX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.